Nurix Therapeutics

📍 San Francisco, United States🗓 Founded 2012👥 286 employees💰 Last funded Sep 2019
Biotechnology🌐 nurixtx.com
Website LinkedIn
Nurix Therapeutics discovers drugs that harness the body's natural process to control protein levels. Our drugs control ubiquitin E3 ligases, the key enzymes responsible for protein breakdown in human cells, as a unique therapeutic approach to treat a broad range of diseases. Our focus is on developing drugs to treat cancer including novel, small molecule immuno-oncology agents.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2012
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Nurix Therapeutics?
Nurix Therapeutics has 1 investors on record on gritt.io and 1 late-stage investors.
When did Nurix Therapeutics last raise funding?
The most recent investment in Nurix Therapeutics recorded on gritt.io was in September 2019.
When was Nurix Therapeutics founded?
Nurix Therapeutics was founded in 2012.
What industry is Nurix Therapeutics in?
Nurix Therapeutics operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Nurix Therapeutics based?
Nurix Therapeutics is headquartered in San Francisco, United States.